Michael Stapleton

|RSS

Michael Stapleton is a Prop Trader for Avatar Securities, specializing in technical analysis and options across multiple asset classes. Prior to that, Stapleton held Prop Trading positions and was a Financial Services Manager at Pershing. Stapleton is a graduate of Rutgers University with a B.A. in Political Science and History and can be followed on Twitter @DonaldKey.

By

Michael Stapleton

 | Sep 30, 2014 | 8:49 AM EDT
This morning PANW announced the availability of its new revolutionary advanced endpoint protection offering called "Traps." It is designed to...
By

Michael Stapleton

 | Sep 26, 2014 | 9:07 AM EDT
Watch the Pimco closed end funds today as their premiums to NAV come out on word that Bill Gross will be leaving the firm for Janus. PTY, PKO, PGP,...
By

Michael Stapleton

 | Sep 24, 2014 | 8:47 AM EDT
I will be revisiting Synnex this week as it prepares to report Q3 earnings next Monday. The stock has been under some pressure the last two weeks...
By

Michael Stapleton

 | Sep 2, 2014 | 1:37 PM EDT
Watching REITs here especially NLY, IVR, TWO and LADR. Reuters running headline that the FHFA is planning on kicking REITs out of the home loan...
By

Michael Stapleton

 | Aug 20, 2014 | 10:45 AM EDT
Infineon set to buy US chipmaker according to Reuters, is Intersil the target? Reuters is reporting that Infineon is poised to buy a U.S. chipmaker...
By

Michael Stapleton

 | Aug 19, 2014 | 9:01 AM EDT
Shares of TASER International (TASR) have been surging in the wake of the situation that occurred in Ferguson last week. The company derives revenue...
By

Michael Stapleton

 | Aug 8, 2014 | 8:53 AM EDT
Shares of Arista Networks (ANET) are on the rise this morning as the company reported solid Q2 earnings. The data switch vendor reported revenues and...
By

Michael Stapleton

 | Jul 25, 2014 | 8:12 AM EDT
Shares of Wellcare are currently indicated down 15% this morning as it shockingly missed 2Q numbers by reporting a loss of 7c a share and lowering...
By

Michael Stapleton

 | Jul 23, 2014 | 8:36 AM EDT
This morning we are seeing PBYI up 270% to 218 on Phase 3 results for their breast cancer drug neratnib. Price targets were moved up to $300 and...
By

Michael Stapleton

 | Jul 17, 2014 | 8:54 AM EDT
Watching trading in NEWL this morning as it continues up another 35%. This little gem has done five reverse stock splits since October of last year (...
The DJIA has been making lows at a fairly regular interval of 101 days. The cycle tools ov...
this stock continues to move well, momentum is strong. BOUGHT JACK MAY 100 CALL A...
I have a special guest joining me today, legendary technician Marc Chaikin comes aboard to...

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.